Dupilumab Drug Substance from United States
Dupilumab Drug Substance is an IL-4/IL-13 inhibitor monoclonal antibody for atopic dermatitis and asthma. It is an unmixed biotechnological immunological product, not in measured doses or retail packaging, and is classified under 3002.13.00.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is not mixed with any additives
• Have documentation showing biotechnological origin
• Check if a Drug Establishment Licence is required for import